Open Monoclonal Technology's Other Investors

Open Monoclonal Technology raised a round of funding on , . Investors include Essex Woodlands.

Open Monoclonal Technology (OMT) is a leader in genetic engineering of animals for the generation of monospecific, bispecific and polyspecific human therapeutic antibodies, as well as naturally optimi…

Articles about Open Monoclonal Technology's Other Investors: